 | • レポートコード：GIR-105X13815 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、仮性狂犬病ウイルスワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。仮性狂犬病ウイルスワクチンの種類別市場規模（不活化ワクチン、天然不足弱毒化ワクチン、遺伝子エンジニアリングワクチン）、用途別市場規模（政府、市場販売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・仮性狂犬病ウイルスワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Merial Limited、Boehringer Ingelheim Animal Health (USA) Co., Ltd.、Zoetis、Hipra、Anhui Divinity Biological Products、Wuhan Keqian Biological Co., Ltd.、China Biotechnology Co., Ltd.、CHINA ANIMAL HUSBANDRY INDUSTRY、Sichuan Huashen、Haley、Tianbang、Dabei Nong、Harvey、Preh Bio、Jiangsu Nannong High-Tech Co.、Guangxi Liyuan Biological Co., Ltd.、Jilin Zhengye Bioengineering Group、Jilin Heyuan Biological Engineering Co., Ltd.、Huapai Biological Engineering Group Co., Ltd.、Beijing Xinde Weite Technology Co., Ltd.、Beijing Veterinary Biopharmaceutical Factory、Qilu Animal Health Products Co., Ltd.、Shanxi Longkel Bio-Pharmaceutical Co., Ltd.、Yunnan Biopharmaceutical Co.、Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.、Liaoning Yikang Biological Co., Ltd.、Shanghui Huahong Biological Engineering Co., Ltd.、Sichuan Hailinge Biological Pharmaceutical Co., Ltd.、Guangdong Yongshun Biological Pharmaceutical Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：不活化ワクチン、天然不足弱毒化ワクチン、遺伝子エンジニアリングワクチン ・用途別分析2016年-2026年：政府、市場販売 ・仮性狂犬病ウイルスワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・仮性狂犬病ウイルスワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・仮性狂犬病ウイルスワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・仮性狂犬病ウイルスワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・仮性狂犬病ウイルスワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pseudorabies Virus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pseudorabies Virus Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pseudorabies Virus Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pseudorabies Virus Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Vaccine
Naturally Deficient Attenuated Vaccine
Genetic Engineering Vaccine
Market segment by Application can be divided into
Government Tender
Market Sales
The key market players for global Pseudorabies Virus Vaccine market are listed below:
Merck
Merial Limited
Boehringer Ingelheim Animal Health (USA) Co., Ltd.
Zoetis
Hipra
Anhui Divinity Biological Products
Wuhan Keqian Biological Co., Ltd.
China Biotechnology Co., Ltd.
CHINA ANIMAL HUSBANDRY INDUSTRY
Sichuan Huashen
Haley
Tianbang
Dabei Nong
Harvey
Preh Bio
Jiangsu Nannong High-Tech Co.
Guangxi Liyuan Biological Co., Ltd.
Jilin Zhengye Bioengineering Group
Jilin Heyuan Biological Engineering Co., Ltd.
Huapai Biological Engineering Group Co., Ltd.
Beijing Xinde Weite Technology Co., Ltd.
Beijing Veterinary Biopharmaceutical Factory
Qilu Animal Health Products Co., Ltd.
Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
Yunnan Biopharmaceutical Co.
Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
Liaoning Yikang Biological Co., Ltd.
Shanghui Huahong Biological Engineering Co., Ltd.
Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pseudorabies Virus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pseudorabies Virus Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Inactivated Vaccine
1.2.3 Naturally Deficient Attenuated Vaccine
1.2.4 Genetic Engineering Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Pseudorabies Virus Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Pseudorabies Virus Vaccine Market Size & Forecast
1.4.1 Global Pseudorabies Virus Vaccine Sales in Value (2016-2026))
1.4.2 Global Pseudorabies Virus Vaccine Sales in Volume (2016-2026)
1.4.3 Global Pseudorabies Virus Vaccine Price by Type (2016-2026) & (USD/Doses)
1.5 Global Pseudorabies Virus Vaccine Production Capacity Analysis
1.5.1 Global Pseudorabies Virus Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Pseudorabies Virus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pseudorabies Virus Vaccine Market Drivers
1.6.2 Pseudorabies Virus Vaccine Market Restraints
1.6.3 Pseudorabies Virus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Pseudorabies Virus Vaccine Product and Services
2.1.4 Merck Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merial Limited
2.2.1 Merial Limited Details
2.2.2 Merial Limited Major Business
2.2.3 Merial Limited Pseudorabies Virus Vaccine Product and Services
2.2.4 Merial Limited Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
2.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Details
2.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Major Business
2.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Zoetis
2.4.1 Zoetis Details
2.4.2 Zoetis Major Business
2.4.3 Zoetis Pseudorabies Virus Vaccine Product and Services
2.4.4 Zoetis Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hipra
2.5.1 Hipra Details
2.5.2 Hipra Major Business
2.5.3 Hipra Pseudorabies Virus Vaccine Product and Services
2.5.4 Hipra Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Anhui Divinity Biological Products
2.6.1 Anhui Divinity Biological Products Details
2.6.2 Anhui Divinity Biological Products Major Business
2.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product and Services
2.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Wuhan Keqian Biological Co., Ltd.
2.7.1 Wuhan Keqian Biological Co., Ltd. Details
2.7.2 Wuhan Keqian Biological Co., Ltd. Major Business
2.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 China Biotechnology Co., Ltd.
2.8.1 China Biotechnology Co., Ltd. Details
2.8.2 China Biotechnology Co., Ltd. Major Business
2.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 CHINA ANIMAL HUSBANDRY INDUSTRY
2.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Details
2.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Major Business
2.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product and Services
2.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Sichuan Huashen
2.10.1 Sichuan Huashen Details
2.10.2 Sichuan Huashen Major Business
2.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Product and Services
2.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Haley
2.11.1 Haley Details
2.11.2 Haley Major Business
2.11.3 Haley Pseudorabies Virus Vaccine Product and Services
2.11.4 Haley Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Tianbang
2.12.1 Tianbang Details
2.12.2 Tianbang Major Business
2.12.3 Tianbang Pseudorabies Virus Vaccine Product and Services
2.12.4 Tianbang Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Dabei Nong
2.13.1 Dabei Nong Details
2.13.2 Dabei Nong Major Business
2.13.3 Dabei Nong Pseudorabies Virus Vaccine Product and Services
2.13.4 Dabei Nong Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Harvey
2.14.1 Harvey Details
2.14.2 Harvey Major Business
2.14.3 Harvey Pseudorabies Virus Vaccine Product and Services
2.14.4 Harvey Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Preh Bio
2.15.1 Preh Bio Details
2.15.2 Preh Bio Major Business
2.15.3 Preh Bio Pseudorabies Virus Vaccine Product and Services
2.15.4 Preh Bio Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Jiangsu Nannong High-Tech Co.
2.16.1 Jiangsu Nannong High-Tech Co. Details
2.16.2 Jiangsu Nannong High-Tech Co. Major Business
2.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product and Services
2.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Guangxi Liyuan Biological Co., Ltd.
2.17.1 Guangxi Liyuan Biological Co., Ltd. Details
2.17.2 Guangxi Liyuan Biological Co., Ltd. Major Business
2.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Jilin Zhengye Bioengineering Group
2.18.1 Jilin Zhengye Bioengineering Group Details
2.18.2 Jilin Zhengye Bioengineering Group Major Business
2.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product and Services
2.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Jilin Heyuan Biological Engineering Co., Ltd.
2.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Details
2.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Major Business
2.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Huapai Biological Engineering Group Co., Ltd.
2.20.1 Huapai Biological Engineering Group Co., Ltd. Details
2.20.2 Huapai Biological Engineering Group Co., Ltd. Major Business
2.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Beijing Xinde Weite Technology Co., Ltd.
2.21.1 Beijing Xinde Weite Technology Co., Ltd. Details
2.21.2 Beijing Xinde Weite Technology Co., Ltd. Major Business
2.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Beijing Veterinary Biopharmaceutical Factory
2.22.1 Beijing Veterinary Biopharmaceutical Factory Details
2.22.2 Beijing Veterinary Biopharmaceutical Factory Major Business
2.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product and Services
2.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Qilu Animal Health Products Co., Ltd.
2.23.1 Qilu Animal Health Products Co., Ltd. Details
2.23.2 Qilu Animal Health Products Co., Ltd. Major Business
2.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
2.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Details
2.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Major Business
2.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.25 Yunnan Biopharmaceutical Co.
2.25.1 Yunnan Biopharmaceutical Co. Details
2.25.2 Yunnan Biopharmaceutical Co. Major Business
2.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product and Services
2.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
2.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Details
2.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Major Business
2.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.27 Liaoning Yikang Biological Co., Ltd.
2.27.1 Liaoning Yikang Biological Co., Ltd. Details
2.27.2 Liaoning Yikang Biological Co., Ltd. Major Business
2.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.28 Shanghui Huahong Biological Engineering Co., Ltd.
2.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Details
2.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Major Business
2.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
2.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Details
2.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Major Business
2.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
2.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Details
2.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Major Business
2.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pseudorabies Virus Vaccine Sales by Manufacturer
3.1 Global Pseudorabies Virus Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pseudorabies Virus Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pseudorabies Virus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pseudorabies Virus Vaccine Manufacturer Market Share
3.4.2 Top 6 Pseudorabies Virus Vaccine Manufacturer Market Share
3.5 Global Pseudorabies Virus Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pseudorabies Virus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pseudorabies Virus Vaccine Market Size by Region
4.1.1 Global Pseudorabies Virus Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Pseudorabies Virus Vaccine Revenue by Region (2016-2026)
4.2 North America Pseudorabies Virus Vaccine Revenue (2016-2026)
4.3 Europe Pseudorabies Virus Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Pseudorabies Virus Vaccine Revenue (2016-2026)
4.5 South America Pseudorabies Virus Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Pseudorabies Virus Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pseudorabies Virus Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Pseudorabies Virus Vaccine Revenue by Type (2016-2026)
5.3 Global Pseudorabies Virus Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pseudorabies Virus Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Pseudorabies Virus Vaccine Revenue by Application (2016-2026)
6.3 Global Pseudorabies Virus Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pseudorabies Virus Vaccine Sales by Type (2016-2026)
7.2 North America Pseudorabies Virus Vaccine Sales by Application (2016-2026)
7.3 North America Pseudorabies Virus Vaccine Market Size by Country
7.3.1 North America Pseudorabies Virus Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Pseudorabies Virus Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pseudorabies Virus Vaccine Sales by Type (2016-2026)
8.2 Europe Pseudorabies Virus Vaccine Sales by Application (2016-2026)
8.3 Europe Pseudorabies Virus Vaccine Market Size by Country
8.3.1 Europe Pseudorabies Virus Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Pseudorabies Virus Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Pseudorabies Virus Vaccine Market Size by Region
9.3.1 Asia-Pacific Pseudorabies Virus Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pseudorabies Virus Vaccine Sales by Type (2016-2026)
10.2 South America Pseudorabies Virus Vaccine Sales by Application (2016-2026)
10.3 South America Pseudorabies Virus Vaccine Market Size by Country
10.3.1 South America Pseudorabies Virus Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Pseudorabies Virus Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Pseudorabies Virus Vaccine Market Size by Country
11.3.1 Middle East & Africa Pseudorabies Virus Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pseudorabies Virus Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pseudorabies Virus Vaccine Typical Distributors
12.3 Pseudorabies Virus Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pseudorabies Virus Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pseudorabies Virus Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Pseudorabies Virus Vaccine Product and Services
Table 6. Merck Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merial Limited Basic Information, Manufacturing Base and Competitors
Table 8. Merial Limited Major Business
Table 9. Merial Limited Pseudorabies Virus Vaccine Product and Services
Table 10. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Major Business
Table 13. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 14. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Zoetis Basic Information, Manufacturing Base and Competitors
Table 16. Zoetis Major Business
Table 17. Zoetis Pseudorabies Virus Vaccine Product and Services
Table 18. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hipra Basic Information, Manufacturing Base and Competitors
Table 20. Hipra Major Business
Table 21. Hipra Pseudorabies Virus Vaccine Product and Services
Table 22. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Anhui Divinity Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Anhui Divinity Biological Products Major Business
Table 25. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product and Services
Table 26. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Wuhan Keqian Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Wuhan Keqian Biological Co., Ltd. Major Business
Table 29. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 30. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. China Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. China Biotechnology Co., Ltd. Major Business
Table 33. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 34. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information, Manufacturing Base and Competitors
Table 36. CHINA ANIMAL HUSBANDRY INDUSTRY Major Business
Table 37. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product and Services
Table 38. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sichuan Huashen Basic Information, Manufacturing Base and Competitors
Table 40. Sichuan Huashen Major Business
Table 41. Sichuan Huashen Pseudorabies Virus Vaccine Product and Services
Table 42. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Haley Basic Information, Manufacturing Base and Competitors
Table 44. Haley Major Business
Table 45. Haley Pseudorabies Virus Vaccine Product and Services
Table 46. Haley Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Tianbang Basic Information, Manufacturing Base and Competitors
Table 48. Tianbang Major Business
Table 49. Tianbang Pseudorabies Virus Vaccine Product and Services
Table 50. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dabei Nong Basic Information, Manufacturing Base and Competitors
Table 52. Dabei Nong Major Business
Table 53. Dabei Nong Pseudorabies Virus Vaccine Product and Services
Table 54. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Harvey Basic Information, Manufacturing Base and Competitors
Table 56. Harvey Major Business
Table 57. Harvey Pseudorabies Virus Vaccine Product and Services
Table 58. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Preh Bio Basic Information, Manufacturing Base and Competitors
Table 60. Preh Bio Major Business
Table 61. Preh Bio Pseudorabies Virus Vaccine Product and Services
Table 62. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Jiangsu Nannong High-Tech Co. Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Nannong High-Tech Co. Major Business
Table 65. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product and Services
Table 66. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Guangxi Liyuan Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Guangxi Liyuan Biological Co., Ltd. Major Business
Table 69. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 70. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Jilin Zhengye Bioengineering Group Basic Information, Manufacturing Base and Competitors
Table 72. Jilin Zhengye Bioengineering Group Major Business
Table 73. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product and Services
Table 74. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Jilin Heyuan Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 76. Jilin Heyuan Biological Engineering Co., Ltd. Major Business
Table 77. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 78. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Huapai Biological Engineering Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Huapai Biological Engineering Group Co., Ltd. Major Business
Table 81. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 82. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Beijing Xinde Weite Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Beijing Xinde Weite Technology Co., Ltd. Major Business
Table 85. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 86. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Beijing Veterinary Biopharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 88. Beijing Veterinary Biopharmaceutical Factory Major Business
Table 89. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product and Services
Table 90. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Qilu Animal Health Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Animal Health Products Co., Ltd. Major Business
Table 93. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 94. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Major Business
Table 97. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 98. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Yunnan Biopharmaceutical Co. Basic Information, Manufacturing Base and Competitors
Table 100. Yunnan Biopharmaceutical Co. Major Business
Table 101. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product and Services
Table 102. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Major Business
Table 105. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 106. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Liaoning Yikang Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. Liaoning Yikang Biological Co., Ltd. Major Business
Table 109. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 110. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Shanghui Huahong Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 112. Shanghui Huahong Biological Engineering Co., Ltd. Major Business
Table 113. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 114. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 115. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Sichuan Hailinge Biological Pharmaceutical Co., Ltd.Major Business
Table 117. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 118. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 119. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Major Business
Table 121. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 122. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 123. Global Pseudorabies Virus Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
Table 124. Global Pseudorabies Virus Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 125. Market Position of Manufacturers in Pseudorabies Virus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 126. Global Pseudorabies Virus Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 127. Head Office and Pseudorabies Virus Vaccine Production Site of Key Manufacturer
Table 128. Global Pseudorabies Virus Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 129. Global Pseudorabies Virus Vaccine Sales by Region (2021-2026) & (M Doses)
Table 130. Global Pseudorabies Virus Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 131. Global Pseudorabies Virus Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 132. Global Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 133. Global Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 134. Global Pseudorabies Virus Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 135. Global Pseudorabies Virus Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 136. Global Pseudorabies Virus Vaccine Price by Type (2016-2021e) & (USD/Doses)
Table 137. Global Pseudorabies Virus Vaccine Price by Type (2021-2026) & (USD/Doses)
Table 138. Global Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 139. Global Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 140. Global Pseudorabies Virus Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 141. Global Pseudorabies Virus Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 142. Global Pseudorabies Virus Vaccine Price by Application (2016-2021e) & (USD/Doses)
Table 143. Global Pseudorabies Virus Vaccine Price by Application (2021-2026) & (USD/Doses)
Table 144. North America Pseudorabies Virus Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 145. North America Pseudorabies Virus Vaccine Sales by Country (2021-2026) & (M Doses)
Table 146. North America Pseudorabies Virus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 147. North America Pseudorabies Virus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 148. North America Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 149. North America Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 150. North America Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 151. North America Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 152. Europe Pseudorabies Virus Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 153. Europe Pseudorabies Virus Vaccine Sales by Country (2021-2026) & (M Doses)
Table 154. Europe Pseudorabies Virus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 155. Europe Pseudorabies Virus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 156. Europe Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 157. Europe Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 158. Europe Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 159. Europe Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 160. Asia-Pacific Pseudorabies Virus Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 161. Asia-Pacific Pseudorabies Virus Vaccine Sales by Region (2021-2026) & (M Doses)
Table 162. Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 163. Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 164. Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 165. Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 166. Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 167. Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 168. South America Pseudorabies Virus Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 169. South America Pseudorabies Virus Vaccine Sales by Country (2021-2026) & (M Doses)
Table 170. South America Pseudorabies Virus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 171. South America Pseudorabies Virus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 172. South America Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 173. South America Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 174. South America Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 175. South America Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 176. Middle East & Africa Pseudorabies Virus Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 177. Middle East & Africa Pseudorabies Virus Vaccine Sales by Country (2021-2026) & (M Doses)
Table 178. Middle East & Africa Pseudorabies Virus Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 179. Middle East & Africa Pseudorabies Virus Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 180. Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 181. Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2021-2026) & (M Doses)
Table 182. Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 183. Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2021-2026) & (M Doses)
Table 184. Direct Channel Pros & Cons
Table 185. Indirect Channel Pros & Cons
Table 186. Pseudorabies Virus Vaccine Typical Distributors
Table 187. Pseudorabies Virus Vaccine Typical Customers
List of Figures
Figure 1. Pseudorabies Virus Vaccine Picture
Figure 2. Global Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 3. Inactivated Vaccine
Figure 4. Naturally Deficient Attenuated Vaccine
Figure 5. Genetic Engineering Vaccine
Figure 6. Global Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 7. Government Tender
Figure 8. Market Sales
Figure 9. Global Pseudorabies Virus Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 10. Global Pseudorabies Virus Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Pseudorabies Virus Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Pseudorabies Virus Vaccine Sales (2016-2026) & (M Doses)
Figure 31. Global Pseudorabies Virus Vaccine Production Capacity (2016-2026) & (M Doses)
Figure 32. Global Pseudorabies Virus Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Pseudorabies Virus Vaccine Market Drivers
Figure 34. Pseudorabies Virus Vaccine Market Restraints
Figure 35. Pseudorabies Virus Vaccine Market Trends
Figure 36. Global Pseudorabies Virus Vaccine Sales Market Share by Manufacturer in 2020
Figure 37. Global Pseudorabies Virus Vaccine Revenue Market Share by Manufacturer in 2020
Figure 38. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Pseudorabies Virus Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Pseudorabies Virus Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2016-2026)
Figure 42. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2016-2026)
Figure 43. North America Pseudorabies Virus Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Europe Pseudorabies Virus Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Pseudorabies Virus Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. South America Pseudorabies Virus Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Pseudorabies Virus Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Global Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2026)
Figure 49. Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2016-2026)
Figure 50. Global Pseudorabies Virus Vaccine Price by Type (2016-2026) & (USD/Doses)
Figure 51. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 52. Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2016-2026)
Figure 53. Global Pseudorabies Virus Vaccine Price by Application (2016-2026) & (USD/Doses)
Figure 54. North America Pseudorabies Virus Vaccine Sales Market Share by Country (2016-2026)
Figure 55. North America Pseudorabies Virus Vaccine Revenue Market Share by Country (2016-2026)
Figure 56. North America Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2026)
Figure 57. North America Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 58. Europe Pseudorabies Virus Vaccine Sales Market Share by Country (2016-2026)
Figure 59. Europe Pseudorabies Virus Vaccine Revenue Market Share by Country (2016-2026)
Figure 60. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2026)
Figure 61. Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pseudorabies Virus Vaccine Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 66. South America Pseudorabies Virus Vaccine Sales Market Share by Country (2016-2026)
Figure 67. South America Pseudorabies Virus Vaccine Revenue Market Share by Country (2016-2026)
Figure 68. South America Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2026)
Figure 69. South America Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pseudorabies Virus Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のインフルエンザウイルスワクチン（H1N1）市場 2021：企業別、地域別、種類・用途別 The Influenza Virus Vaccine (H1N1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界のガーダシル（HPVワクチン）市場 2021：企業別、地域別、種類・用途別 The Gardasil (HPV Vaccine) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の遺伝子ワクチン市場 2021：企業別、地域別、種類・用途別 The Genetic Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- ヒトのワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administ…
- 日本脳炎ワクチンの世界市場2018-2025 Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.…